loadpatents
name:-0.019787788391113
name:-0.014679908752441
name:-0.016499042510986
LIAO; Lv Patent Filings

LIAO; Lv

Patent Applications and Registrations

Patent applications and USPTO patent grants for LIAO; Lv.The latest application filed is for "novel naphthyridinone derivatives and their use in the treatment of arrhythmia".

Company Profile
12.16.21
  • LIAO; Lv - Shanghai CN
  • LIAO; Lv - Pudong CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia
App 20210284635 - BARBE; Guillaume ;   et al.
2021-09-16
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors
App 20210155606 - ARISTA; Luca ;   et al.
2021-05-27
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
Grant 10,947,218 - Arista , et al. March 16, 2
2021-03-16
Naphthyridinone derivatives and their use in the treatment of arrhythmia
Grant 10,844,055 - Barbe , et al. November 24, 2
2020-11-24
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors
App 20200299265 - ARISTA; Luca ;   et al.
2020-09-24
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
Grant 10,710,980 - Arista , et al.
2020-07-14
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Grant 10,507,201 - Buschmann , et al. Dec
2019-12-17
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Grant 10,463,653 - Liao , et al. No
2019-11-05
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia
App 20190263803 - BARBE; Guillaume ;   et al.
2019-08-29
Use Of Ring-fused Bicyclic Pyridyl Derivatives As Fgfr4 Inhibitors
App 20190231760 - BUSCHMANN; Nicole ;   et al.
2019-08-01
Aminopyridine Derivatives And Their Use As Selective Alk-2 Inhibitors
App 20190161474 - ARISTA; Luca ;   et al.
2019-05-30
Naphthyridinone derivatives and their use in the treatment of arrhythmia
Grant 10,266,531 - Barbe , et al.
2019-04-23
Use Of Ring-fused Bicyclic Pyridyl Derivatives As Fgfr4 Inhibitors
App 20190076412 - BUSCHMANN; Nicole ;   et al.
2019-03-14
Pharmaceutical combinations
Grant 10,130,629 - Buschmann , et al. November 20, 2
2018-11-20
Use Of Ring-fused Bicyclic Pyridyl Derivatives As Fgfr4 Inhibitors
App 20180185341 - BUSCHMANN; Nicole ;   et al.
2018-07-05
Novel Naphthyridinone Derivatives And Their Use In The Treatment Of Arrhythmia
App 20180111932 - BARBE; Guillaume ;   et al.
2018-04-26
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Grant 9,896,449 - Buschmann , et al. February 20, 2
2018-02-20
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2- -oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
Grant 9,802,917 - Buschmann , et al. October 31, 2
2017-10-31
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
App 20170066766 - Buschmann; Nicole ;   et al.
2017-03-09
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Grant 9,533,988 - Buschmann , et al. January 3, 2
2017-01-03
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2- -oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
App 20160304489 - BUSCHMANN; Nicole ;   et al.
2016-10-20
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
App 20160102092 - Buschmann; Nicole ;   et al.
2016-04-14
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
Grant 9,266,883 - Buschmann , et al. February 23, 2
2016-02-23
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
App 20150119385 - Buschmann; Nicole ;   et al.
2015-04-30
Imidazopyrrolidinone Compounds
App 20140343084 - FURET; Pascal ;   et al.
2014-11-20
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
Grant 8,815,926 - Furet , et al. August 26, 2
2014-08-26
Cyclic Nucleuoside Derivatives And Uses Thereof
App 20140205566 - LIAO; Lv ;   et al.
2014-07-24
Imidazopyrrolidinone Compounds
App 20140011798 - FURET; Pascal ;   et al.
2014-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed